ICON Announces the Appointment of Dr. Steve Cutler to Board of Directors
25 Novembro 2015 - 9:00AM
Business Wire
ICON plc, (NASDAQ:ICLR) a global provider of drug
development solutions and services to the pharmaceutical,
biotechnology and medical device industries, today announced the
appointment of Dr. Steve Cutler to the ICON Board of Directors.
Dr. Cutler joined ICON in 2011 as Group President, ICON Clinical
Research Services. Dr. Cutler successfully led this business to
significant growth and, as a result, was promoted to Chief
Operating Officer in January 2014. As Chief Operating Officer, Dr.
Cutler has responsibility for all of ICON’s operational service
areas, including clinical research, early phase, laboratories, DOCS
resourcing and commercialisation and outcomes. Dr. Cutler’s
operational leadership as Chief Operating Officer has helped ICON
successfully deliver innovative and integrated services and
solutions to customers.
Prior to joining ICON, Dr. Cutler was Chief Executive Officer of
Kendle. Prior to Kendle, Dr. Cutler held various senior roles in
both Quintiles and Sandoz (now Novartis). Dr. Cutler holds a B.Sc.
and a Ph.D from the University of Sydney and a Masters of Business
Administration from the University of Birmingham (UK).
“Since joining ICON in 2011, Dr. Cutler has made a significant
contribution to ICON and our journey towards becoming the trusted
partner in drug development,” commented Mr. Thomas Lynch, Chairman
of ICON. “I am delighted to now welcome Dr. Cutler to the ICON
Board and I look forward to his continued success with and
contribution to ICON.”
About ICON plc
ICON plc is a global provider of drug development solutions and
services to the pharmaceutical, biotechnology and medical device
industries. The company specialises in the strategic development,
management and analysis of programs that support clinical
development - from compound selection to Phase I-IV clinical
studies. With headquarters in Dublin, Ireland, ICON currently,
operates from 77 locations in 38 countries and has approximately
11,700 employees.
Further information is available at www.iconplc.com.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
ICON/ICLR-F
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151125005161/en/
ICON plcInvestor Relations, 1-888-381-7923orBrendan Brennan, +
353 –1-291-2000Chief Financial OfficerorSimon Holmes, + 353
–1-291-2000EVP Investor Relations and Corporate Development
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024